Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Abliva Free Cash Flow (Quarterly): -0.0813M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0813M |
| September 30, 2023 | -0.4611M |
| June 30, 2023 | 0.3932M |
| March 31, 2023 | -0.7095M |
| December 31, 2022 | -1.353M |
| September 30, 2022 | -9.654M |
| June 30, 2022 | -2.553M |
| March 31, 2022 | -2.439M |
| December 31, 2021 | -4.864M |
| September 30, 2021 | -3.438M |
| June 30, 2021 | -3.533M |
| March 31, 2021 | -1.621M |
| December 31, 2020 | -1.027M |
| September 30, 2020 | -2.044M |
| June 30, 2020 | -1.480M |
| March 31, 2020 | -2.982M |
| December 31, 2019 | -2.321M |
| September 30, 2019 | -1.961M |
| June 30, 2019 | -1.418M |
| March 31, 2019 | -2.251M |
| December 31, 2018 | -1.674M |
| September 30, 2018 | -1.358M |
| June 30, 2018 | -3.135M |
| March 31, 2018 | -1.634M |
| December 31, 2017 | -0.9838M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.322M |
| June 30, 2017 | -2.354M |
| March 31, 2017 | -1.658M |
| December 31, 2016 | -2.336M |
| September 30, 2016 | -1.440M |
| June 30, 2016 | -3.054M |
| March 31, 2016 | -2.024M |
| December 31, 2015 | -2.494M |
| September 30, 2015 | -2.289M |
| June 30, 2015 | -3.136M |
| March 31, 2015 | -2.836M |
| December 31, 2014 | -1.502M |
| September 30, 2014 | -1.921M |
| June 30, 2014 | -3.377M |
| March 31, 2014 | -3.016M |
| December 31, 2013 | -1.330M |
| September 30, 2013 | -1.23M |
| June 30, 2013 | -0.6977M |
| March 31, 2013 | -1.47M |
| December 31, 2012 | -0.9355M |
| September 30, 2012 | -0.9091M |
| June 30, 2012 | -0.9775M |
| March 31, 2012 | -0.42M |
| December 31, 2011 | -0.4405M |
| September 30, 2011 | -0.653M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.654M
Minimum
Sep 2022
0.3932M
Maximum
Jun 2023
-2.292M
Average
-1.961M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| Karolinska Development AB | -0.6572M |
| Calliditas Therapeutics AB | -- |
| Oncopeptides AB | -4.947M |
| Olink Holding AB | -11.09M |
| BioInvent International AB | -6.574M |